300006 莱美药业
2025/03 - 三个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)-0.737-4.439-0.425-3.210-6.042
总资产报酬率 ROA (%)-0.501-3.056-0.300-2.297-3.310
投入资产回报率 ROIC (%)-0.593-3.623-0.360-2.799-4.112

边际利润分析
销售毛利率 (%)56.81964.38869.33073.49871.466
营业利润率 (%)-7.685-13.3016.278-10.857-5.725
息税前利润/营业总收入 (%)-9.144-11.865-2.123-7.963-7.057
净利润/营业总收入 (%)-7.036-10.066-1.119-8.624-8.646

收益指标分析
经营活动净收益/利润总额(%)58.399115.869-2,145.438151.840119.260
价值变动净收益/利润总额(%)59.28524.9912,421.015-7.682-45.226
营业外收支净额/利润总额(%)-0.030-40.090-1,464.312-27.63133.806

偿债能力分析
流动比率 (X)2.4592.2082.9282.4892.590
速动比率 (X)2.1571.9572.6242.2012.353
资产负债率 (%)29.08634.05226.59128.48324.418
带息债务/全部投入资本 (%)15.82420.73611.57914.8407.790
股东权益/带息债务 (%)523.672376.362735.392568.4871,157.975
股东权益/负债合计 (%)242.287192.839270.667244.128301.736
利息保障倍数 (X)6.2575.0050.841-14.654-4.432

营运能力分析
应收账款周转天数 (天)123.092134.811131.612153.285133.152
存货周转天数 (天)205.059236.777244.692276.541233.973